Find out how our comprehensive hematology test menu aids in diagnosis and treatment across a wide range of complex pediatric hematologic disorders.
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
Widening the net to capture elusive pathogens - Insights
Central nervous system infections, such as meningitis and encephalitis, can be devastating for affected patients. While specific treatments are available for some of these infections, it first requires identifying the precise cause of...
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
How the COVID-19 pandemic has increased public knowledge of lab testing - Insights
While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
Pathways Case Studies: September 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for September include the following sub-specialties: Cardiovascular Pathology,...
Helicobacter pylori Infection: Serologic Testing Not Recommended [Communiqué] - Insights
Helicobacter pylori (H pylori) infection is among the most common bacterial infections worldwide with approximately one-half of the world’s population infected. Several invasive and noninvasive testing methods are available to detect H...
Phlebotomy Top Gun: Order of Draw-Do We Still Care? - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will cover the need and evidence behind following the order of draw recommendations for routine blood collection. Specifically, does evidence demonstrate a need to collect serum tubes...
MCL - Informed Consent for Genetic Testing (Spanish) - MC1235-117SP
MCL - Informed Consent Genetic Testing (Spanish)
Mayo Clinic Labs @Work: Shannon Bennett - Insights
As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of...
Mayo Clinic Labs @Work: Lisa Wortman Raring - Insights
In her role as a proposal writer, Lisa Wortman Raring helps show clients everything Mayo Clinic Laboratories has to offer, making it clear how the organization can best meet their needs and the needs of their patients.
Mayo Clinic Labs @Work: Heather Van Buskirk - Insights
As a client account representative, Heather Van Buskirk uses her problem-solving skills to make sure invoices get paid in a timely manner, so Mayo Clinic Laboratories’ services remain available to providers and their patients.
Mayo Clinic Labs @Work: Daniel Kronemann - Insights
As a clinical laboratory technologist, Daniel Kronemann enjoys going beyond his day-to-day work as he explores new ways to enhance processes and systems in Bacteriology.
Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights
Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...
Cardiology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and cardiology patient-care clinics allows us to reduce downstream costs with care-driven...
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 3 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
FISH probe & panel project: An overview - Insights
In this month's "Hot Topic," Jess Peterson, M.D., discusses changes to Mayo Clinic Laboratories’ hematology FISH menu to increase awareness, provide reasoning, and highlight some of the great things that are coming.
Medical Drones: High Hopes, Grounded in Science - Insights
While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.
Mayo Clinic Team to Combat Arboviruses and Future Infectious Disease Threats in Belize - Insights
Mayo Clinic and the University of Notre Dame’s Eck Institute for Global Health have launched a four-tiered joint project to better characterize and further assist in the detection of vector-borne infectious diseases in Belize.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Mayo Clinic Labs @Work: Tim Brantner - Insights
Before he arrived at Mayo Clinic, Tim Brantner worked for a variety of organizations outside of health care. He joined Mayo Clinic Laboratories 14 years ago to help tell the labs’ story.
Building a Scientific Collaborative Space - Insights
Combining innovative Mayo Clinic laboratories with medical businesses and creative start-up companies will help Rochester—and benefit patients.
Preparation of Platelet-Poor Plasma for Special Coagulation Testing - Insights
In this months "Hot Topic," Christopher Desens, MLS(ASCP) discusses the preparation of platelet-poor plasma for coagulation testing.
Laboratory testing utilization: Coccidioides immitis/posadasii serologic testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., shares the recommended approach to serologic testing for assessment or infection with coccidioides.
Direct immunofluorescence for autoimmune bullous diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
Highlighting MML Regional Service Representatives - Insights
Our Mayo Medical Laboratory regional service representatives provide outstanding support to our clients and have the opportunity to share the Mayo Clinic mission and expertise with laboratories around the world. To gain a good understanding...
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Our staff, our stories: Rondell Graham - Insights
Dr. Graham recalls how his upbringing influenced his outlook on life and discusses the power of investing in relationships.
Lessons from Leaders: Who Let the DOGs Out? - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing, interviews Amy Clayton, M.D., Division Chair of Anatomic Pathology at Mayo Clinic, about "disease-oriented groups," which are multidisciplinary teams formed to establish a...
Winter Activities: Safety Tips - Insights
Here in Minnesota, we have entered into the time of year that is either loved or hated by Minnesotans: winter. In honor of Winter Hazard Awareness Week, November 6–10, Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, suggests resources...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Mayo Clinic Laboratories’ robust portfolio of clinically supported assays to test for marijuana use is consistent with professional recommendations.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...